Conversely, injection forms, though being painful and needing help of medical personnel for application, help to quickly achieve necessary concentration of preparation in blood doxycycline online Antibiotic is usually chosen in an empiric way (at random). But when choosing one is obligatory guided by definite rules.

Pi080331050

Testing laboratory accredited by the DAP Deutsche Akkreditierungssystem Prüfwesen GmbH according to DIN EN ISO/IEC 17025. The accreditation is only valid for the test methods marked with (a). ANALYSIS REPORT No. 080402093
DATE: 02.04.2008
Green Card S.A.
Via Luserte sud 8
6572 QUARTINO
SCHWEIZ

Our reference no.
: PI080331050
: 60 % Royal Jelly Powder 40 % Longan fruit Powder - DG071012
Sample temp. when received / stored : Room temperature ANALYSIS REQUESTED: Chloramphenicol by Liquid Chromatography - Mass Spectrometry
n.d. - not detected < MRPL of 0.3 µg/kg (2003/181/EC dated 13.03.2003) (a) : accredited method. (A) : Inhouse procedure. This document may only be reproduced in full. The results given herein apply to the submitted sample only. Interpretation:
Regarding the examined parameters and the mentioned minimum required performance limit (MRPL) the sample
corresponds to the legal regulations (Decision 2003/181/EC dated March 13th, 2003 in connection
with the Decision 2005/34/EC dated January 11th, 2005).
Dr. Kurt-Peter RaezkeDipl.-Chemiker, Dr.rer.nat / Prüfleiter Testing laboratory accredited by the DAP Deutsche Akkreditierungssystem Prüfwesen GmbH according to DIN EN ISO/IEC 17025. The accreditation is only valid for the test methods marked with (a). ANALYSIS REPORT No. 080401070
DATE: 01.04.2008
Green Card S.A.
Via Luserte sud 8
6572 QUARTINO
SCHWEIZ

Our reference no.
: PI080331050
: 60 % Royal Jelly Powder 40 % Longan fruit Powder - DG071012
Sample temp. when received / stored : Room temperature ANALYSIS REQUESTED: Tetracyclines by Liquid Chromatography - Mass Spectrometry
n.d. - not detected < limit of quantification 10 µg/kg; n.a. - not analyzed (a) : accredited method. (A) : Inhouse procedure. This document may only be reproduced in full. The results given herein apply to the submitted sample only. Interpretation:
Regarding the examined parameters and the mentioned limit of quantification the sample corresponds
to the legal regulations (German ordinance about maximum residue levels RHmV dated 21/10/1999,
in connection with EU regulation (EEC) 2377/90 dated 26/06/1990).
Dr. Kurt-Peter RaezkeDipl.-Chemiker, Dr.rer.nat / Prüfleiter Testing laboratory accredited by the DAP Deutsche Akkreditierungssystem Prüfwesen GmbH according to DIN EN ISO/IEC 17025. The accreditation is only valid for the test methods marked with (a). ANALYSIS REPORT No. 080404234
DATE: 04.04.2008
Green Card S.A.
Via Luserte sud 8
6572 QUARTINO
SCHWEIZ

Our reference no.
: PI080331050
: 60 % Royal Jelly Powder 40 % Longan fruit Powder - DG071012
Sample temp. when received / stored : Room temperature ANALYSIS REQUESTED: Nitrofurane Metabolites by Liquid Chromatography - Mass Spectrometry
n.d. - not detected < 0.5 µg/kg MRPL (Minimum Required Performance limit) for nitrofurane metabolites = 1.0 µg/kg according to 2003/181/EG dated March 13, 2003 (A) : Inhouse procedure. This document may only be reproduced in full. The results given herein apply to the submitted sample only. Interpretation:
Regarding the examined parameters and the mentioned minimum required performance limit (MRPL) the sample
corresponds to the legal regulations (Decision 2003/181/EC dated March 13th, 2003 in connection
with the Decision 2005/34/EC dated January 11th, 2005).
Dr. Kurt-Peter RaezkeDipl.-Chemiker, Dr.rer.nat / Prüfleiter

Source: http://www.lafemmeroyale.ch/down/PI080331050.pdf

Microsoft word - spct2009e_clean.doc

OSTEOCIS ® TECHNICAL LEAFLET: SUMMARY OF PRODUCT CHARACTERISTICS TRADE NAME OF THE MEDICINAL PRODUCT Kit for the preparation of Technetium [99mTc] Oxidronate Injection QUALITATIVE AND QUANTITATIVE COMPOSITION OSTEOCIS®, kit for the preparation of Technetium [99mTc] Oxidronate Injection, consists of 5 multidose vials, each containing the following sterile, pyrogen-free, freeze

www1.saude.rs.gov.br

Porto Alegre, quarta-feira, 12 de dezembro de 2007 DIÁRIO OFICIAL Anexo II: Requisitos Mínimos de Apresentação dos LaudosNa 1ª Fase do programa serão selecionados cinco medicamentos, enquadrados entre os mais manipulados e medicamentos sujeitos a controle Especial (Port. 344/98), na forma farmacêutica de Os critérios para a coleta dos medicamentos nas fases seguintes serão estabelec

Copyright © 2010-2014 Medical Articles